Larvol Delta - ACCUTE-Phase-III-Efficacy-and-Safety-Study-of-AB103-in-the-Treatment-of-Patients-With-Necrotizing-Soft-Tissue-Infections

reltecimod (AB103) - Atox Bio

http://clinicaltrials.gov/ct2/show/NCT02469857

Jun 4, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next